Home
Conditions
Non-Hodgkin's Lymphoma

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Active, not recruiting

PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study

NCT01269593

Conditions: Active Solid Malignancy, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, not recruiting

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

NCT01746849

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +20 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, not recruiting

Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)

NCT02050347

Conditions: B-Cell ALL, B-Cell CLL, Burkitt Lymphoma, +21 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas

NCT00877214

Conditions: Chronic Disease, Disease Attributes, Follicular Lymphomas, +23 more
Locations: StiL Head Office; Justus-Liebig-University Giessen, Germany

View Trial Details

Completed

Vaccination With Flt3L, Radiation, and Poly-ICLC

NCT03789097

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +19 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

NCT03317899

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

NCT01592370

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Local Institution - 0035 Clovis, California, United States

Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States

Local Institution - 0012 Los Angeles, California, United States

Local Institution - 0017 Aurora, Colorado, United States

View all 43 locations

View Trial Details

Completed

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

NCT02356159

Conditions: Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

National Marrow Donor Program Minneapolis, Minnesota, United States

View Trial Details

Completed

Living Conditions After Non-Hodgkin's Lymphoma in France

NCT05583318

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Chu Dijon Bourgogne Dijon, France

View Trial Details

Completed

Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide

NCT01458366

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma trial results

Related conditions